Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell death.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 03 2022
Historique:
received: 23 03 2021
accepted: 14 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 6 5 2022
Statut: epublish

Résumé

Nigratine (also known as 6E11), a flavanone derivative of a plant natural product, was characterized as highly specific non-ATP competitive inhibitor of RIPK1 kinase, one of the key components of necroptotic cell death signaling. We show here that nigratine inhibited both necroptosis (induced by Tumor Necrosis Factor-α) and ferroptosis (induced by the small molecules glutamate, erastin, RSL3 or cumene hydroperoxide) with EC

Identifiants

pubmed: 35332201
doi: 10.1038/s41598-022-09019-w
pii: 10.1038/s41598-022-09019-w
pmc: PMC8944179
doi:

Substances chimiques

Tumor Necrosis Factor-alpha 0
Receptor-Interacting Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5118

Informations de copyright

© 2022. The Author(s).

Références

Cell Death Discov. 2017 Feb 27;3:17013
pubmed: 28250973
Future Med Chem. 2014 Apr;6(5):485-7
pubmed: 24649950
Int J Mol Sci. 2019 Oct 08;20(19):
pubmed: 31597407
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9714-9722
pubmed: 31048504
Trends Cell Biol. 2016 Mar;26(3):165-176
pubmed: 26653790
Nat Rev Drug Discov. 2004 Apr;3(4):353-9
pubmed: 15060530
Clin Transl Med. 2018 Jan 17;7(1):3
pubmed: 29340951
Front Microbiol. 2021 Mar 03;12:631654
pubmed: 33746925
Nat Chem Biol. 2005 Jul;1(2):112-9
pubmed: 16408008
FEBS J. 2017 Sep;284(18):3050-3068
pubmed: 28715128
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970
Nat Rev Drug Discov. 2016 May;15(5):348-66
pubmed: 26775689
Biotechnol J. 2007 Jan;2(1):68-75
pubmed: 17225251
Cell Death Differ. 2017 Jul;24(7):1184-1195
pubmed: 28498367
Front Neurosci. 2018 Apr 20;12:214
pubmed: 29731704
Sci Rep. 2017 Oct 10;7(1):12931
pubmed: 29018243
Eur J Med Chem. 2020 Sep 1;201:112337
pubmed: 32659605
PLoS One. 2019 Mar 28;14(3):e0214250
pubmed: 30921410
EMBO J. 2019 Feb 15;38(4):
pubmed: 30643021
Trends Pharmacol Sci. 2020 Mar;41(3):209-224
pubmed: 32035657
J Med Chem. 2018 Sep 13;61(17):7640-7656
pubmed: 30078314
Lancet. 1995 Dec 9;346(8989):1533-40
pubmed: 7491052
Mol Microbiol. 2022 Mar;117(3):682-692
pubmed: 34605588
Med Res Rev. 2021 Sep;41(5):2606-2633
pubmed: 32557696
Nat Commun. 2020 Jun 19;11(1):3151
pubmed: 32561730
Cell Death Dis. 2020 Jan 29;11(1):73
pubmed: 31996668
Nat Commun. 2021 Jul 20;12(1):4402
pubmed: 34285231
Eur J Med Chem. 2020 Feb 15;188:112025
pubmed: 31931340
Methods Mol Biol. 2013;979:65-70
pubmed: 23397389
J Am Soc Nephrol. 2015 Nov;26(11):2647-58
pubmed: 25788533
J Clin Invest. 2019 Nov 1;129(11):5033-5049
pubmed: 31437128
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479

Auteurs

Claire Delehouzé (C)

SeaBeLife Biotech, Place Georges Teissier, 29680, Roscoff, France.
Sorbonne Université, CNRS, UMR 8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, 29680, Roscoff, France.

Arnaud Comte (A)

Université de Lyon, CNRS UMR 5246, ICBMS, Chimiothèque, Université Claude Bernard Lyon 1, 69622, Villeurbanne, France.

Stephen Adonai Leon-Icaza (SA)

Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, CNRS, UPS, Toulouse, France.

Céline Cougoule (C)

Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, CNRS, UPS, Toulouse, France.

Marcelle Hauteville (M)

Laboratoire de Biochimie Analytique et Synthèse Bioorganique, Université de Lyon, Université Claude Bernard Lyon 1, 69622, Villeurbanne, France.

Peter Goekjian (P)

Université de Lyon, CNRS UMR 5246, ICBMS, Laboratoire Chimie Organique 2-Glycosciences, Université Claude Bernard Lyon 1, 69622, Villeurbanne, France.

Jeannette Chloë Bulinski (JC)

Sorbonne Université, CNRS, UMR 8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, 29680, Roscoff, France.
Department of Biological Sciences, Columbia University, New York, NY, 10027, USA.

Marie-Thérèse Dimanche-Boitrel (MT)

Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, 35000, Rennes, France.

Etienne Meunier (E)

Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, CNRS, UPS, Toulouse, France.

Morgane Rousselot (M)

SeaBeLife Biotech, Place Georges Teissier, 29680, Roscoff, France. morgane.rousselot@seabelife.com.

Stéphane Bach (S)

Sorbonne Université, CNRS, UMR 8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, 29680, Roscoff, France. bach@sb-roscoff.fr.
Sorbonne Université, CNRS, FR 2424, Plateforme de Criblage KISSf (Kinase Inhibitor Specialized Screening Facility), Station Biologique de Roscoff, 29680, Roscoff Cedex, France. bach@sb-roscoff.fr.
Centre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom, 2520, South Africa. bach@sb-roscoff.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH